Predicción y previsión de precio de Xenon Pharmaceuticals Inc (XENE)XENEXenon Pharmaceuticals Inc

Alphio's XENE stock price prediction model matches the current Xenon Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $35.08 (-0.73%). The 1-week path is $35.41 (+0.21%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Xenon Pharmaceuticals is currently not a strong buy due to its recent stock decline and ongoing clinical trial issues, despite having a solid cash position of $1.25 billion. The stock is currently priced at $35.34, which is significantly below the analyst target of $73 from Guggenheim, indicating potential upside. However, the RSI is at 44.25, suggesting it is nearing oversold conditions, and the stock has seen a 25% drop due to a pause in clinical trials, which poses a significant risk. Therefore, while there is potential for recovery, caution is advised due to the recent volatility and uncertainty surrounding its clinical programs.

Xenon Pharmaceuticals Inc (XENE) last closed at $35.34, losing -3.18%. These facts feed the 1-day and 1-week XENE price prediction above.